|ITEM METADATA RECORD
|Title: ||Vandetanib plus pemetrexed versus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer (NSCLC): A randomized, double-blind phase III trial (ZEAL)|
|Authors: ||De Boer, R|
Blackhall, F. H
Yang, C. H
Vansteenkiste, Johan #
|Issue Date: ||2009 |
|Publisher: ||Grune & Stratton|
|Host Document: ||Journal of Clinical Oncology vol:27 issue:15 pages:Suppl.S|
|Conference: ||45th Annual Meeting of the American-Society-of-Clinical-Oncology location:Orlando, FL date:29 May-02 June 2009|
|Publication status: ||published|
|KU Leuven publication type: ||IMa|
|Appears in Collections:||Pneumology|
|Files in This Item:
There are no files associated with this item.
All items in Lirias are protected by copyright, with all rights reserved.